Hormonal insufficiency of the hypothalamic–pituitary–adrenal (HPA) axis is a common complication in patients who have undergone pituitary surgery. Different procedures are used to assess HPA function ...

"As an emerging leader in melanocortin research, we now have the opportunity with Synacthen to expand and accelerate our product development activities. We believe such efforts will enhance our ...

Injecting performance enhancing corticosteroid hormones for other than medical treatment is banned, and tests exist that can detect injected hormones. Injecting synacthen, which stimulates the body to ...

Until now there has been no test that could detect synacthen, which when injected simulates the body to produce extra amounts of its own corticosteroid. This is most common in sports where sports ...

The researchers estimate that the at-home test could reduce the number of Short Synacthen Tests undertaken for diagnosing adrenal insufficiency, from 92,000 per year to just 23,000 across England. The ...

Questcor Pharmaceuticals, announced that the transaction acquiring rights to Synacthen and Synacthen depot from Novartis Pharma AG and Novartis AG in certain countries outside the US. has now closed.